[Disclosure] Samsung Biologics (207940) – Decision on Debt Guarantee for Others / 2026-03-20
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has resolved to provide a payment guarantee of approximately KRW 332.9B for the real estate lease agreement of a US entity acquired through its wholly owned US subsidiary. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Changes in…